ArticleClinical and experimental immunology1998

Aminoguanidine reduces glomerular inducible nitric oxide synthase (iNOS) and transforming growth factor-beta 1 (TGF-beta1) mRNA expression and diminishes glomerulosclerosis in NZB/W F1 mice.

C W Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.